Discover
CRDF
Cardiff Oncology, Inc.
1.29
2 x 0.92
2 x 1.62
bid
ask
-
0.01
0.77%
2 @ 04:00 PM
1.26 -0.03 (1.98%)
| Ytd | -54.09% | |
| 1y | -63.25% |
1.26
day range
1.30
1.16
52 week range
4.56
| Open | 1.28 | Prev Close | 1.30 | Low | 1.26 | High | 1.30 | Mkt Cap | 88.20M |
| Vol | 564.19K | Avg Vol | 1.21M | EPS | -0.67 | P/E | N/A | Forward P/E | -4.03 |
| Beta | 1.93 | Short Ratio | 8.06 | Inst. Own | 27.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.57 | 200-d Avg | 1.99 | 1yr Est | 10.75 |
CRDF News
benzinga.com
Craig-Hallum Downgrades Cardiff Oncology to Hold, Lowers Price Target to $2
Craig-Hallum analyst Albert Lowe downgrades Cardiff Oncology (NASDAQ:CRDF) from Buy to Hold and l
benzinga.com
Cardiff Oncology Announces Presentation Of Phase 2 Trial Data For RAS-Mutated mCRC Treatment Onvanse
Data Highlights from the ongoing Phase 2 trial (Data cut: March 18, 2026):In the intent-to-treat (IT
benzinga.com
This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Resident